Clinical Trial Update: A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of eliglustat tartrate in adults with type 1 Gaucher disease has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Eliglustat Tartrate (Eliglustat tartrate)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-09-03